Related references
Note: Only part of the references are listed.Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
W. Joseph Herring et al.
BIOLOGICAL PSYCHIATRY (2016)
Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease
Hong Sun et al.
RESPIRATORY MEDICINE (2015)
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
David Michelson et al.
LANCET NEUROLOGY (2014)
Orexin (Hypocretin) Receptor Agonists and Antagonists for Treatment of Sleep Disorders Rationale for Development and Current Status
Michihiro Mieda et al.
CNS DRUGS (2013)
Orexin receptor antagonism for treatment of insomnia A randomized clinical trial of suvorexant
W. Joseph Herring et al.
NEUROLOGY (2012)
Orexin Receptors: Pharmacology and Therapeutic Opportunities
Thomas E. Scammell et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Promotion of Sleep by Suvorexant--A Novel Dual Orexin Receptor Antagonist
Christopher J. Winrow et al.
JOURNAL OF NEUROGENETICS (2011)
Ventilatory chemoresponsiveness, narcolepsy-cataplexy and human leukocyte antigen DQB1☆0602 status
F. Han et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle
Aihua Li et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Hypothalamic orexins/hypocretins as regulators of breathing
Rhîannan H. Williams et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
Orexinergic modulation of breathing across vigilance states
Tomoyuki Kuwaki
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2008)
Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice
Ben-Shiang Deng et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea
Meir Kryger et al.
SLEEP AND BREATHING (2007)
A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome
Russell Rosenberg et al.
SLEEP MEDICINE (2007)
Promotion of sleep by targeting the orexin system in rats, dogs and humans
Catherine Brisbare-Roch et al.
NATURE MEDICINE (2007)
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
Takeshi Sakurai
NATURE REVIEWS NEUROSCIENCE (2007)
Hypocretins (orexins) and sleep-wake disorders
CR Baumann et al.
LANCET NEUROLOGY (2005)
Orexin stimulates breathing via medullary and spinal pathways
JK Young et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Sleep-disordered breathing, glucose intolerance, and insulin resistance - The Sleep Heart Health Study
NM Punjabi et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Frequency of insomnia report in patients with Obstructive Sleep Apnoea Hypopnea Syndrome (OSAHS)
S Smith et al.
SLEEP MEDICINE (2004)
Prevalence of insomnia symptoms in patients with sleep-disordered breathing
B Krakow et al.
CHEST (2001)
The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders
TS Kilduff et al.
TRENDS IN NEUROSCIENCES (2000)
Prospective study of the association between sleep-disordered breathing and hypertension
PE Peppard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
